This ongoing feature series was taken from the 4th annual postgraduate course and workshop in medical mycology-dermatomycology, July 27-30, 1979, Newport Beach, CA. This month's case is sporotrichosis, a disease classically known as rose gardener's disease, as the infection can result after being pricked by a contaminted rose thorn.

Sporotrichosis is a deep cutaneous mycotic infection caused by the dimorphic organism Sporothrix schenckii (Figure 1).

New Products
P 46

DNA Scar Therapy Improves Appearance of Scars

According to a press release from DNA EGF Renewal, its DNA Scar Therapy uses a combination of enzymes, silicone, sunflower seed oil and beta glucan to speed up the healing process and make scars appear smoother and less noticeable.

Discovery of new DNA ‘Hotspots’ Could Aid in Developing New Therapies

Whether or not they realize it, says this team dermatologist for the Baltimore Orioles, dermatologists who treat disorders such as folliculitis, verruca, actinic keratoses and cold urticaria, are practicing sports dermatology.

Sports dermatology may sound more intimidating to the practitioner than it should. Just because you think you don’t know much about sports doesn’t mean you don’t practice “sports dermatology.”

Which medications and procedures are safe for pregnant patients? Valerie Hanft, MD, answers questions about pregnancy-related skin issues, cosmetic procedures and over-the-counter drugs, and reviews the FDA pregnancy safety ratings for common dermatology medications.

As dermatologists we all have our individual styles of practice and favorite areas of dermatology on which we prefer to focus. But we all share one thing in common: We have a strong desire to improve our skills. Getting input from colleagues can help us achieve this goal, and it was why this column was created.

Superficial cutaneous fungal infections are among the most common dermatologic complaints encountered in ambulatory practice, affecting millions of people worldwide; the estimated overall lifetime risk of acquiring such an infection is somewhere between 10% and 20%.1 The clinical presentation of dermatophyte infections varies, dependent on both the exuberance of the host immune response and the ty

The FDA recently announced that the manufacturers of tumor necrosis factor alpha blockers (TNF-alpha blockers) must strengthen the existing warnings about the risk of developing opportunistic fungal infections when taking these drugs.

Marketing to Consumers
More money than ever is being spent on direct-to-consumer advertising,
making patients aware of which prescriptions to request.

The amount spent to advertise prescription drugs directly to the consumer has increased significantly, according to a recent study by the National Institute for Health Care Management Research and Educational Foundation.